Treatment of Multidrug Resistant (MDR1) Murine Leukemia with P-Glycoprotein Substrates Accelerates the Course of the Disease
Authors:
- Jin-Ming YangJYJin-Ming Yang
- Guang-Yu YangGYGuang-Yu Yang
- Daniel J. MedinaDMDaniel J. Medina
- Andrew D. VassilAVAndrew D. Vassil
- Jie LiaoJLJie Liao
- William N. HaitWHWilliam N. Hait
- 1 December 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 266 (1) , 167-173
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- P-glycoprotein and multidrug resistanceCurrent Opinion in Genetics & Development, 1996
- bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvementBiochemical Journal, 1995
- Establishment and in vivo characterization of multidrug‐resistant dunning R3327 rat prostate‐carcinoma cell‐linesInternational Journal of Cancer, 1994
- Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteinsCell, 1994
- Measurement of intracellular pH using flow cytometry with carboxy‐SNARF‐1Cytometry, 1993
- Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in VivoScience, 1990
- Over‐expression of MDR gene with no dna amplification in a multiple‐drug‐resistant human ovarian carcinoma cell lineInternational Journal of Cancer, 1989
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinBiochemical and Biophysical Research Communications, 1986
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976